Marcel Muskiet

20142020
If you made any changes in Pure these will be visible here soon.

Research Output 2014 2020

2020

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function

van Bommel, E. J. M., Ruiter, D., Muskiet, M. H. A., van Baar, M. J. B., Kramer, M. H. H., Nieuwdorp, M., Joles, J. A., Bjornstad, P. & van Raalte, D. H., 2020, In : Diabetes Care. 43, 1, p. 228-234

Research output: Contribution to journalArticleAcademicpeer-review

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

Spit, K. A., Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Joles, J. A., de Boer, A. & van Raalte, D. H., Feb 2020, In : Magnetic Resonance Materials in Physics, Biology and Medicine. 33, 1, p. 73-80

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Combining GLP-1 Receptor Agonists and Basal Insulin in Older Adults with Type 2 Diabetes: Focus on Lixisenatide and Insulin Glargine

Handelsman, Y., Muskiet, M. H. A. & Meneilly, G. S., 2019, In : Advances in therapy. 36, 12, p. 3321-3339

Research output: Contribution to journalReview articleAcademicpeer-review

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

Muskiet, M. H. A., Bunck, M. C., Heine, R. J., Cornér, A., Yki-Järvinen, H., Eliasson, B., Joles, J. A., Diamant, M., Tonneijck, L. & van Raalte, D. H., 1 Jul 2019, In : Diabetes Research and Clinical Practice. 153, p. 14-22 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

New pharmacological strategies for protecting kidney function in type 2 diabetes

Muskiet, M. H. A., Wheeler, D. C. & Heerspink, H. J. L., 1 May 2019, In : The Lancet Diabetes and Endocrinology. 7, 5, p. 397-412

Research output: Contribution to journalReview articleAcademicpeer-review

Plasma uric acid and renal haemodynamics in type 2 diabetes patients

Suijk, D. L. S., Smits, M. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Joles, J. A. & van Raalte, D. H., 1 Jan 2019, In : Nephrology (Carlton, Vic.).

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus

Tonneijck, L., Muskiet, M. H. A., Blijdorp, C. J., Smits, M. M., Twisk, J. W., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., Hoorn, E. J. & van Raalte, D. H., 2019, In : American Journal of Physiology. Renal Physiology. 316, 2, p. F231-F240

Research output: Contribution to journalArticleAcademicpeer-review

2018

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Bjornstad, P., Kramer, M. H. H., Diamant, M., Hoorn, E. J., Joles, J. A. & van Raalte, D. H., 2018, In : Diabetes, Obesity and Metabolism. 20, 5, p. 1235-1245

Research output: Contribution to journalArticleAcademicpeer-review

GLP-1 receptor agonists, CKD, and eGFR trajectory

van Baar, M. J. B., van Raalte, D. H. & Muskiet, M. H. A., 2018, In : Lancet diabetes & endocrinology. 6, 10, p. 764-765 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial

Pranger, I. G., van Raalte, D. H., Brands, M., Muskiet, M. H. A., Kema, I. P., Serlie, M. J., Diamant, M., Bakker, S. J. L. & Muskiet, F. A. J., 2018, In : Prostaglandins, Leukotrienes and Essential Fatty Acids. 132, p. 8-15

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Muskiet, M. H. A., Tonneijck, L., Huang, Y., Liu, M., Saremi, A., Heerspink, H. J. L. & van Raalte, D. H., 2018, In : The Lancet Diabetes and Endocrinology. 6, 11, p. 859-869

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide versus insulin glulisine on fasting and postbreakfast systemic hemodynamics in type 2 diabetes mellitus patients

Tonneijck, L., Muskiet, M. H. A., Twisk, J. W., Kramer, M. H. H., Jan Danser, A. H., Joles, J. A., Smits, M. M. & van Raalte, D. H., 2018, In : Hypertension. 72, 2, p. 314-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renal outcomes in CVOTs: keep calm and carry on

Muskiet, M. H. A., van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 1 Sep 2018, In : The Lancet Diabetes and Endocrinology. 6, 9, p. 674-676 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

2017

Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L. & van Raalte, D. H., Apr 2017, In : Diabetic Medicine. 34, 4, p. 591-592 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Van Bommel, E. J., Heerspink, H. J. L., Van Raalte, D. H. & Joles, J. A., 1 Apr 2017, In : Journal of the American Society of Nephrology. 28, 4, p. 1023-1039 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

GLP-1 and the kidney: From physiology to pharmacology and outcomes in diabetes

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Van Baar, M. J. B., Kramer, M. H. H., Hoorn, E. J., Joles, J. A. & Van Raalte, D. H., 1 Oct 2017, In : Nature Reviews Nephrology. 13, 10, p. 605-628 24 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Liraglutide and renal outcomes in type 2 diabetes

Tonneijck, L., Van Raalte, D. H. & Muskiet, M. H. A., 30 Nov 2017, In : New England Journal of Medicine. 377, 22, p. 2195 1 p.

Research output: Contribution to journalLetterAcademicpeer-review

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pieters-van den Bos, I. C., Vendrik, K. E. W., Hoekstra, T., Bruno, M. J., Diamant, M., van Raalte, D. H. & Cahen, D. L., Mar 2017, In : Diabetes Care. 40, 3, p. 301-308 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Pancreatic Steatosis Is Not Associated with Exocrine Pancreatic Function in Overweight Type 2 Diabetes Patients

Vendrik, K. E. W., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pouwels, P. J. W., Pieters-Van Den Bos, I. C., Diamant, M., Cahen, D. L., Van Raalte, D. H. & Smits, M. M., 1 Oct 2017, In : Pancreas. 46, 9, p. e75-e76

Research output: Contribution to journalLetterAcademicpeer-review

SGLT2 inhibition: a new era in renoprotective medicine?

Muskiet, M. H. A., Heerspink, H. J. L. & van Raalte, D. H., 1 Aug 2017, In : The Lancet Diabetes and Endocrinology. 5, 8, p. 569-571 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

2016

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial

Tonneijck, L., Smits, M. M., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A. & van Raalte, D. H., Jul 2016, In : Diabetologia. 59, 7, p. 1412-1421

Research output: Contribution to journalArticleAcademicpeer-review

Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M., Diamant, M., Joles, J. A. & van Raalte, D. H., Feb 2016, In : Diabetes, Obesity and Metabolism. 18, 2, p. 178-185

Research output: Contribution to journalArticleAcademicpeer-review

Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes

Muskiet, M. H. A., van Bommel, E. J. M. & van Raalte, D. H., Mar 2016, In : Lancet diabetes & endocrinology. 4, 3, p. 188-189

Research output: Contribution to journalComment/Letter to the editorAcademic

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

Muskiet, M. H. A., Tonneijck, L. & Smits, M. M., 9 Jun 2016, In : New England Journal of Medicine. 374, 23, p. 2291-2291

Research output: Contribution to journalComment/Letter to the editorAcademic

Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patients

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Hoekstra, T., Kramer, M. H. H., Diamant, M., Nieuwdorp, M., Groen, A. K., Cahen, D. L. & van Raalte, D. H., Dec 2016, In : Diabetes, Obesity and Metabolism. 18, 12, p. 1217-1225

Research output: Contribution to journalArticleAcademicpeer-review

GLP-1 based therapies: clinical implications for gastroenterologists

Smits, M. M., van Raalte, D. H., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H. & Cahen, D. L., Apr 2016, In : Gut. 65, 4, p. 702-11 10 p.

Research output: Contribution to journalArticleAcademicpeer-review

Renoprotection in LEADER and EMPA-REG OUTCOME

Muskiet, M. H. A., Tonneijck, L., van Bommel, E. J. M., Smits, M. M. & van Raalte, D. H., 2016, In : Lancet diabetes & endocrinology. 4, 10, p. 812-4 3 p.

Research output: Contribution to journalArticleAcademicpeer-review

Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial

Muskiet, M. H. A., Tonneijck, L. & van Raalte, D. H., 2015, In : Circulation. 132, 6, p. E120-E120

Research output: Contribution to journalMeeting AbstractOther research output

Incretin-based drugs and renoprotection-is hyperfiltration key?

Tonneijck, L., Smits, M. M., van Raalte, D. H. & Muskiet, M. H. A., 2015, In : Kidney International. 87, 3, p. 660-661

Research output: Contribution to journalArticleAcademicpeer-review